Retinal vascular disease in hypertension: Risk factor modification optimizes vision outcomes

Postgraduate Medicine

Volumn 117, Issue 6, 2005, Pages 33-42

  Colucciello, Michael ^a,b  

^a South Jersey Eye Physicians   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ALCOHOL; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CARBON DIOXIDE; CHLORPROMAZINE; CYANOCOBALAMIN; FOLIC ACID; GLYCERYL TRINITRATE; NITROQUICK; OXYGEN; PHENYLEPHRINE; PYRIDOXINE; TISSUE PLASMINOGEN ACTIVATOR; TRIAMCINOLONE; TROPICAMIDE; VASCULOTROPIN;

CONFERENCE PAPER; ENUCLEATION; EYE PAIN; HUMAN; HYPERTENSION; LASER COAGULATION; MICROANEURYSM; NEOVASCULAR GLAUCOMA; OPHTHALMIC ARTERY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RETINA ARTERY OCCLUSION; RETINA BLOOD VESSEL OCCLUSION; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; RETINA VEIN OCCLUSION; VITRECTOMY; VITREOUS HEMORRHAGE; ARTICLE; PROGNOSIS; RETINA DISEASE; RISK FACTOR; TREATMENT OUTCOME; VASCULAR DISEASE; VISUAL DISORDER;

HUMANS; HYPERTENSION; PROGNOSIS; RETINAL ARTERY OCCLUSION; RETINAL DISEASES; RETINAL VEIN OCCLUSION; RISK FACTORS; TREATMENT OUTCOME; VASCULAR DISEASES; VISION DISORDERS; VITRECTOMY; VITREOUS HEMORRHAGE;

EID: 22844444189     PISSN: 00325481     EISSN: 12182583     Source Type: Journal    
DOI: 10.3810/pgm.2005.06.1662     Document Type: Conference Paper

References (16)

1. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289(19):2560-72
2. [Erratum, JAMA 2003;290 (2): 197]
3. Simons BD, Brucker AJ. Branch retinal vein occlusion: axial length and other risk factors. Retina 1997;17(3):191-5
4. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol 1996;114(10):1243-7
5. Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994;117(4):429-41
6. Christoffersen NL, Larsen M. Pathophysiology and hemodynamics of branch retinal vein occlusion. Ophthalmology 1999;106(11):2054-62
7. Patz A. Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. Am J Ophthalmol 1984;98(3):271-82
8. Mester U, Dillinger P. Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina 2002;22(6):740-6
9. Mandelcorn MS, Nrusimhadevara RK. Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases. Retina 2004;24(3):348-55
10. Justice J Jr, Lehmann RP. Cilioretinal arteries: a study based on review of stereo fundus photographs and fluoroscein angiographic findings. Arch Ophthalmol 1976;94(8):1355-8
11. Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol 1997;115(4):486-91
12. [Erratum, Arch Ophthalmol 1997;115(10):1275]
13. Zhao P, Hayashi H, Oshima K et al. Vitrectomy for macular hemorrhage associated with retinal arterial macroaneurysm. Ophthalmology 2000;107(3):613-7
14. Colucciello M, Nachbar JG. Macular hole following ruptured retinal arterial macroaneurysm. Retina 2000;20(1):94-6
15. Toth CA, Morse LS, Hjelmeland LM, et al. Fibrin directs early retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol 1991;109(5):723-9
16. Lorentzen SE. Occlusion of the central retinal artery: a follow-up. Acta Ophthalmol 1969;47:690-703